Changeflow GovPing Government General Medline Industries Class 1 Recall of Syringe Ad...
Urgent Enforcement Amended Final

Medline Industries Class 1 Recall of Syringe Adaptor Medical Convenience Kits

Favicon for changeflow.com FDA Device Recalls (Class I)
Filed
Detected
Email

Summary

FDA classified a Class 1 device recall for Medline Industries medical convenience kits containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes. The recall addresses 82 kits (Lot 25LMJ532 and Lot 24KMI274) distributed worldwide due to potential risk of the syringe rotating adaptor unwinding during use, which may cause loose connection or full disconnection between the syringe and manifold. Affected consignees must quarantine product, complete the response form, and remove/discard affected syringes from kits.

Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

FDA classified a Class 1 device recall for Medline Industries medical convenience kits (SHOULDER ARTHROSCOPY PACK SKU DYNJ30880M and EXTREMITY PACK SKU DYNJ64295A) containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes. The recall was initiated after post-market surveillance identified a potential risk of the syringe rotating adaptor unwinding during use, which could result in a loose connection and/or full disconnection between the syringe and manifold.\n\nHealthcare facilities and distributors holding affected product must immediately quarantine inventory, complete the required response form, and remove and discard the defective Namic RA Syringes from all kits. Medline Industries will provide over-labels via FedEx overnight for affected inventory, with instructions for staff to properly remove the component prior to kit use. Distributors are required by FDA regulations to notify their customers who received the affected product. The recall affects 82 kits distributed worldwide including nationwide US distribution and OUS to Canada, Netherlands, Australia, Korea, Sri Lanka, Pakistan, Japan, UAE, Singapore, and Slovakia.

What to do next

  1. Check stock immediately for affected item and lot numbers and quarantine all product
  2. Complete the response form listing quantity of affected product in inventory
  3. Remove and discard affected Namic RA Syringes from kits before use
  4. If a distributor or reseller, notify downstream customers of this recall communication per FDA regulations

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 1 Device Recall Medline medical convenience kits

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 1 Device Recall Medline medical convenience kits | |

Date Initiated by Firm February 27, 2026
Date Posted April 07, 2026
Recall Status Open , Classified
Recall Number Z-1730-2026
Recall Event ID 98598
Product Classification Orthopedic tray - Product Code OJH
Product Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows:
  1. SHOULDER ARTHROSCOPY PACK, Medline SKU # DYNJ30880M;
    1. EXTREMITY PACK, Medline SKU # DYNJ64295A. | | Code Information | 1. Medline SKU # DYNJ30880M, UDI/DI each 10198459446207, UDI/DI case 40198459446208, Lot Number: 25LMJ532;
  2. Medline SKU # DYNJ64295A, UDI/DI each 10193489353853, UDI/DI case 40193489353854, Lot Number: 24KMI274. | | FEI Number | 1417592 | | Recalling Firm/ Manufacturer | Medline Industries, LP 3 Lakes Dr Northfield IL 60093-2753 | | For Additional Information Contact | Haley Barclay 866-359-1704 | | Manufacturer Reason for Recall | Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. | | FDA Determined Cause | Under Investigation by firm | | Action | Medline Industries, LP issued an "URGENT MEDICAL DEVICE RECALL" notice to its consignees on 2/27/2026 via USPS and email. The notice explained the issue, risk associated with syringe disconnection and loose connection, and request customers remove and destroy all Namic RA Syringes. Over-labels will be provided for any affected kits on hand stating that the affected syringes must be removed and discarded from further use. The only exception is in rare circumstances where angiography is urgently required, no alternative device is available, and postponing the procedure would place the patient at significant risk. Required Action: Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product.

If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com. |
| Quantity in Commerce | 82 kits |
| Distribution | Worldwide distribution: US (nationwide) including Puerto Rico (PR) and OUS (foreign) to countries of: Canada (CA), Netherlands (NL), Australia (AU), Korea, Republic of (KR), Sri Lanka (LK), Pakistan (PK), Japan (JP), United Arab Emirates (AE), Singapore (SG) and Slovakia (SK). |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.

3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

Get daily alerts for FDA Device Recalls (Class I)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
February 27th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Recall Number Z-1730-2026

Who this affects

Applies to
Medical device makers Healthcare providers Distributors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Product safety response Device market withdrawal
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class I) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!